Clinical Trial Update: Long-term Study of Ciclosporin for Atopic Dermatitis [Phase 3]

View source ↗

Summary

This document reports the completion of a long-term Phase 3 study evaluating ciclosporin for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ciclosporin (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Severe Atopic Dermatitis | Phase 3 | Status: COMPLETED